FDA Investigator Michelle D Haamid

Michelle D Haamid has inspections in 4 countries as of 29 Sep 2023. Michelle D Haamid has collaborated with a combined 3071 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
Last Inspection Date:
29 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
United States of America, Germany, India, Portugal
A Williams, Adam R Cooke, Alan P Kurtzberg, Alberto A Viciedo, Allen F Hall, Amanda L Evanco, Amy H Ruble, Angela Shepas, Anthony J Grace, April R Bowen, Babatunde D Babalola, Barbara Frazier, Barbara M Frazier, Betsy C Galliher, Billy M Battles, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brian A Graves, Brian S Lynch, Brown, Buford, Candido Torres, Cara M Minelli, Carl E Lovrich, Carol F Robinson, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, CDR Thomas R Berry, PPh, Charanjeet Jassal, Chateryl K Washington, Cheryl A Grandinetti, Cheryl D Barton, Chestnut, Christie B Rice, Christine M O'leary, Christopher B May, Claudele S Razo, Claudette D Brooks, Cordelia J Brammer, Courtney A Gilbert, Craig A Garmendia, Cress S Hall, Cynthia A Harris, MD, RN, Cynthia F Kleppinger, MD, Darcy E Brillhart, Dawn M Braswell, Debra J Tucker, Dellarese L Herbert, Derek C Price, Devaughn Edwards, Doretha M Tonkins, Doretha M Wilson, Dr. Robert C Horan, MD, Dr. Sriram Subramaniam, PhD, Edecia A Richards, Edward Deberry, Eileen J Bannerman, Ernest H Blackwood, Esra Toussaint, Felix Maldonado, Gabriel R Mclemore, Gamal A Norton, Gary E Coleman, Jr, REHS, Gerald N Mcgirl, DDS, Harperd, Heather Akleimola Hulbert, Heather M Wheeler, Helen R Bester, Hristu B Chepa, Inga M Warr, Jacqueline D Mitchell, James C Maclaughlin, James I Giefer, James P Lewis, Jr, Jared P Stevens, Jawaid Hamid, Jessica A Stephens, Jessica Fields, Joe A Odom, John D White, Jorge F Christian, Jorge L Gonzalez, Joseph F Owens, June P Page, Justin A Boyd, Karen A Coleman, Kassa Ayalew, MD, Kathleen D Culver, Kenneth L Smalls, Kevin D Kallander, Kimberly Cdelk Brooks, Kip J Hanks, Kristen E Rescigno, Lareese K Thomas, Latorie S Jones, Laureen F Kononen, Lauren L Vajo, Lawrence Thomas, Leon L Crawley, Leslie W Gilbert, Libia M Lugo, Lillie D Witcher, Mancia R Walker, Marcia A Worley, Marla A Cassidy, Mary Alice Papdimitriou, Mary T Carden, Matthew B Casale, Melanie W Pishnery, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michael A Charles, Michael F Skelly, PhD, Michelle D Hamid, Michelle Haamid, Morrell, Myla D Chapman, Nicholas M Smith, Nicole M Bell, Nigel L Hirth, Noreen Muniz, Omotunde O Osunsanmi, Pamela L Vega, Patricia F Hudson, Paul A Bonneau, Paul W Moy, Paula J Bretz, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Randy D Baxter, Randy L Clarida, Rashonda N Rucker, Reba A Gates, Richard J Bashay, Richard L Garcia, Robert W Jennings, Robin N Goins, Rose Xu, Russell R Zablan, Saeid E Kazan, Samuel L Murray, Sayeeda Hdabe, Scott B Laufenberg, Seneca D Toms, Sereen Gmorgan Murray, Shelley H Beausoleil, Sheri S Oliver, Sondra M Rates, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Srira Subramaniam, PhD, Stardust W Mazzariello, State Agency, Stephanie Mangigian, MS/OSH, RN, Tajah L Blackburn, Tallman, Torrance J Slayton, Traci M Armand, Tracy R Ball, Trang N Cox, Valerie J Grecek Trinh, Vanessa E Coulter, Vicky C Stoakes, Victoria Hampshire, Vincent M Williams, Viviana Matta, Wayne D Mcgrath, William P Tonkins

Michelle D Haamid's Documents

Publish Date Document Type Title
May, 2009 FDA 483 Joseph O Moore MD - Form 483, 2009-05-06
February, 2000 EIR Kitzman, Dalane, W. MD - EIR, 2000-02-18
April, 2002 EIR Ward, Walter, A., Dr. - EIR, 2002-04-29
March, 2004 EIR Bayer AG - EIR, 2004-03-25
June, 2000 EIR Arnold, Gordon, Dr. - EIR, 2000-06-23
January, 2003 FDA 483 Laboratory Corp Of America - Form 483, 2003-01-28
January, 2005 FDA 483 Charter Medical Limited - Form 483, 2005-01-25
February, 2011 EIR Duke University Health System Irb - EIR, 2011-02-04
July, 2001 EIR Catalent Pharma Solutions, LLC - EIR, 2001-07-27
January, 2004 FDA 483 Novartis Animal Health US Inc - Form 483, 2004-01-23
September, 2002 EIR Miracles in Sight - EIR, 2002-09-18
January, 2003 EIR Laboratory Corp Of America - EIR, 2003-01-28
July, 2001 FDA 483 Catalent Pharma Solutions, LLC - Form 483, 2001-07-27
September, 2003 EIR Idexx Pharmaceuticals Inc - EIR, 2003-09-04
November, 2007 EIR Idexx Pharmaceuticals Inc - EIR, 2007-11-14
October, 2003 EIR Ginger Williams, DVM - EIR, 2003-10-09
January, 2001 EIR Crouse, John R. MD - EIR, 2001-01-30
May, 2013 FDA 483 Steven Rohrbeck - Form 483, 2013-05-06
April, 2002 EIR Family Health International - EIR, 2002-04-02
June, 2009 EIR GlaxoSmithKline - EIR, 2009-06-11
February, 2000 EIR Dean, Christine Joan MD - EIR, 2000-02-08
March, 2004 FDA 483 Grifols Therapeutics Inc. - Form 483, 2004-03-25
January, 2001 FDA 483 Wake Forest University School of Medicine - Form 483, 2001-01-30
January, 2001 EIR Abbott Laboratories - EIR, 2001-01-11
March, 2003 EIR Professional Lab & Research - EIR, 2003-03-28
February, 2000 FDA 483 Epilepsy Institute of NC - Form 483, 2000-02-08
October, 2000 EIR Roberts, Lynn - EIR, 2000-10-18
October, 2002 EIR Professional Lab & Research - EIR, 2002-10-16
March, 2001 EIR Laboratory Corp Of America - EIR, 2001-03-06
April, 2001 EIR John Burkart, MD - EIR, 2001-04-12
May, 2013 EIR Steven Rohrbeck - EIR, 2013-05-06

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles


Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more